TherapeuticsMD, Inc. (TXMD)

USD 1.42

(2.16%)

EBITDA Summary of TherapeuticsMD, Inc.

  • TherapeuticsMD, Inc.'s latest annual EBITDA in 2023 was -8.4 Million USD , down -139.39% from previous year.
  • TherapeuticsMD, Inc.'s latest quarterly EBITDA in 2024 Q1 was -1 Million USD , up 21.58% from previous quarter.
  • TherapeuticsMD, Inc. reported an annual EBITDA of 11.85 Million USD in 2022, up 115.75% from previous year.
  • TherapeuticsMD, Inc. reported an annual EBITDA of -78.56 Million USD in 2021, up 10.25% from previous year.
  • TherapeuticsMD, Inc. reported a quarterly EBITDA of -999 Thousand USD for 2024 Q2, down -27.96% from previous quarter.
  • TherapeuticsMD, Inc. reported a quarterly EBITDA of -2.24 Million USD for 2023 Q2, down -0.31% from previous quarter.

Annual EBITDA Chart of TherapeuticsMD, Inc. (2023 - 1991)

Historical Annual EBITDA of TherapeuticsMD, Inc. (2023 - 1991)

Year EBITDA EBITDA Growth
2023 -8.4 Million USD -139.39%
2022 11.85 Million USD 115.75%
2021 -78.56 Million USD 10.25%
2020 -149.47 Million USD -2.42%
2019 -156.3 Million USD -15.41%
2018 -127.64 Million USD -64.88%
2017 -76.71 Million USD 13.74%
2016 -89.74 Million USD -5.42%
2015 -85.12 Million USD -57.92%
2014 -53.98 Million USD -109.82%
2013 -25.68 Million USD -59.23%
2012 -26.39 Million USD -198.2%
2011 -12.79 Million USD -1230.76%
2010 -384.43 Thousand USD 74.09%
2009 -1.56 Million USD -296.78%
2008 -395.55 Thousand USD -321.95%
2007 -51 Thousand USD -121.5%
2006 -80.81 Thousand USD 10.96%
2005 437.73 Thousand USD 59.47%
2004 238.75 Thousand USD -11.32%
2003 208.46 Thousand USD 109.1%
2002 131.88 Thousand USD -3.34%
2001 137.44 Thousand USD -24.11%
2000 200.32 Thousand USD 193.34%
1999 61.49 Thousand USD 63.23%
1998 37.82 Thousand USD -46.24%
1997 70.37 Thousand USD -26.1%
1996 95.22 Thousand USD 55.95%
1995 66.34 Thousand USD -10.63%
1994 66.66 Thousand USD 8.43%
1993 63.65 Thousand USD 0.0%
1992 - USD 0.0%
1991 - USD 0.0%

Peer EBITDA Comparison of TherapeuticsMD, Inc.

Name EBITDA EBITDA Difference
Esperion Therapeutics, Inc. -150.1 Million USD 94.403%
Theratechnologies Inc. -10.31 Million USD 18.538%
Safety Shot Inc -12.18 Million USD 31.056%
Cosmos Health Inc. -17.06 Million USD 50.761%
Cronos Group Inc. -72.14 Million USD 88.356%
Ironwood Pharmaceuticals, Inc. -924.86 Million USD 99.092%
Kala Pharmaceuticals, Inc. -36.08 Million USD 76.717%
Organogenesis Holdings Inc. 36.03 Million USD 123.316%
Universe Pharmaceuticals INC -3.21 Million USD -161.301%
ProPhase Labs, Inc. -14.82 Million USD 43.34%
Sonoma Pharmaceuticals, Inc. -4.52 Million USD -85.657%
Dynavax Technologies Corporation 9.66 Million USD 186.913%
Radius Health, Inc. 38.31 Million USD 121.929%
China SXT Pharmaceuticals, Inc. -2.35 Million USD -257.336%
Alvotech -484.86 Million USD 98.267%
Sunshine Biopharma, Inc. -3.82 Million USD -119.667%
Alpha Teknova, Inc. -25.53 Million USD 67.105%
Intra-Cellular Therapies, Inc. -158.85 Million USD 94.711%
SCYNEXIS, Inc. 73.47 Million USD 111.433%
Harrow Health, Inc. 9.72 Million USD 186.403%
Biofrontera Inc. -18.45 Million USD 54.474%
DURECT Corporation -24.68 Million USD 65.966%
Supernus Pharmaceuticals, Inc. 98.26 Million USD 108.55%
ANI Pharmaceuticals, Inc. 109.32 Million USD 107.685%
OptiNose, Inc. -15.55 Million USD 45.985%
RedHill Biopharma Ltd. 26.26 Million USD 131.984%
Aquestive Therapeutics, Inc. 1.18 Million USD 810.745%
Cumberland Pharmaceuticals Inc. -710.85 Thousand USD -1081.825%
SIGA Technologies, Inc. 84.15 Million USD 109.982%
Lifecore Biomedical, Inc. 812 Thousand USD 1134.606%
Shineco, Inc. -26.55 Million USD 68.362%
Phibro Animal Health Corporation 84.6 Million USD 109.929%
Procaps Group S.A. 104.02 Million USD 108.076%
Regencell Bioscience Holdings Limited -3.61 Million USD -132.224%
Viatris Inc. 3.51 Billion USD 100.239%
Sunshine Biopharma, Inc. -3.82 Million USD -119.667%
Rockwell Medical, Inc. -4.69 Million USD -78.973%
Incannex Healthcare Limited -18.5 Million USD 54.599%
Aytu BioPharma, Inc. -1.01 Million USD -730.138%
Tilray Brands, Inc. -72.84 Million USD 88.467%
Collegium Pharmaceutical, Inc. 308.32 Million USD 102.725%
PetIQ, Inc. 81.48 Million USD 110.31%
Silver Spike Investment Corp. 7.34 Million USD 214.453%
Neurocrine Biosciences, Inc. 416.1 Million USD 102.019%
Journey Medical Corporation 1.92 Million USD 537.324%
Alimera Sciences, Inc. 7.27 Million USD 215.462%
Petros Pharmaceuticals, Inc. -4.21 Million USD -99.46%
Assertio Holdings, Inc. -222.44 Million USD 96.223%
Shuttle Pharmaceuticals Holdings, Inc. -3.99 Million USD -110.517%
Embecta Corp. 245.4 Million USD 103.423%
Cyclo Therapeutics, Inc. -20.03 Million USD 58.06%
Procaps Group, S.A. 104.02 Million USD 108.076%
PainReform Ltd. -9.56 Million USD 12.206%
Avadel Pharmaceuticals plc -149.12 Million USD 94.366%
Hempacco Co., Inc. -12.77 Million USD 34.23%
Talphera, Inc. -9.84 Million USD 14.641%
Pacira BioSciences, Inc. 162.89 Million USD 105.157%
Alvotech -484.86 Million USD 98.267%
Lantheus Holdings, Inc. 491 Million USD 101.711%
Kamada Ltd. 21.53 Million USD 139.013%
Indivior PLC 66 Million USD 112.729%
Currenc Group, Inc. -1.9 Million USD -342.024%
Evoke Pharma, Inc. -7.29 Million USD -15.204%
Flora Growth Corp. -45.87 Million USD 81.685%
Cyclo Therapeutics, Inc. -20.03 Million USD 58.06%
Evolus, Inc. -41.81 Million USD 79.907%
HUTCHMED (China) Limited 25.52 Million USD 132.909%
Amphastar Pharmaceuticals, Inc. 241.46 Million USD 103.479%
Akanda Corp. -27.73 Million USD 69.711%